InvestSMART

Firebrick Pharma Limited (ASX: FRE) - Announcements

Current share price for FRE : $0.033 0.007 (26.92%)+

ASX company news and announcements for Firebrick Pharma Limited (FRE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Firebrick Pharma Limited (FRE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Firebrick Pharma Limited (FRE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Firebrick Pharma Limited (FRE)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$9 Proposed issue of securities - FRE 10 Aug 2026 8:41AM $0.026 $0.033 risen by 26.92%
$9 Update - Notification regarding unquoted securities - FRE 27 Jul 2026 3:26PM $0.027 $0.033 risen by 22.22%
$9 Investor Update 27 Jul 2026 9:33AM $0.028 $0.033 risen by 17.86%
$9 June 2026 Quarterly Activity Report 27 Jul 2026 9:32AM $0.028 $0.033 risen by 17.86%
$9 Change of Address 14 Jul 2026 12:00PM $0.030 $0.033 risen by 10%
$9 Results of General Meeting 22 Jun 2026 11:21AM $0.036 $0.033 fallen by 8.33%
$9 Nasodine Composition Patent Granted in New Zealand 3 Jun 2026 8:20AM $0.042 $0.033 fallen by 21.43%
$9 Cleansing Notice 2 Jun 2026 8:31AM $0.045 $0.033 fallen by 26.67%
$9 Application for quotation of securities - FRE 2 Jun 2026 8:29AM $0.045 $0.033 fallen by 26.67%
$9 Proposed issue of securities - FRE 1 Jun 2026 8:40AM $0.042 $0.033 fallen by 21.43%
$9 Notification of cessation of securities - FRE 1 Jun 2026 8:24AM $0.042 $0.033 fallen by 21.43%
$9 Change in substantial holding 29 May 2026 7:11PM $0.042 $0.033 fallen by 21.43%
$9 Notice of GM & Proxy Form & Access Letter 22 May 2026 9:23AM $0.046 $0.033 fallen by 28.26%
$9 Cleansing Notice 21 May 2026 4:59PM $0.046 $0.033 fallen by 28.26%
$9 Application for quotation of securities - FRE 21 May 2026 4:58PM $0.046 $0.033 fallen by 28.26%
$9 Change of Director's Interest Notice - Peter Molloy 21 May 2026 10:10AM $0.046 $0.033 fallen by 28.26%
$9 Change of Director's Interest Notice - Stephen Goodall 21 May 2026 9:02AM $0.040 $0.033 fallen by 17.50%
$9 Close of Offer - Listing Options 20 May 2026 4:50PM $0.040 $0.033 fallen by 17.50%
$9 Cleansing Prospectus - Listing of Options 15 May 2026 9:31AM $0.049 $0.033 fallen by 32.65%
$9 Options Top 20 Holders Report 14 May 2026 2:57PM $0.049 $0.033 fallen by 32.65%
$9 Options Range Report 14 May 2026 2:55PM $0.049 $0.033 fallen by 32.65%
$9 Application for quotation of securities - FRE 14 May 2026 2:54PM $0.049 $0.033 fallen by 32.65%
$9 Nasodine patent accepted in Canada 13 May 2026 12:17PM $0.048 $0.033 fallen by 31.25%
$9 Firebrick investor webinar update 22 Apr 2026 11:02AM $0.062 $0.033 fallen by 46.77%
$9 March 2026 Quarterly Activity Report & Appendix 4C 21 Apr 2026 4:50PM $0.062 $0.033 fallen by 46.77%

1 - 25 of 505 results

Page 1 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.